At this time, given limited clinical availability of cystatin-C, we recommend addition of cystatin-C by utilizing the 2021 CKD-EPI combined creatinine and cystatin-C equation when more precision is required in the absence of non-GFR determinants for either biomarker. The gene discussed is CST3; the disease is chronic kidney disease.